Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers.
- 1 June 1986
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 8 (6_pt_2) , II96-105
- https://doi.org/10.1161/01.hyp.8.6_pt_2.ii96
Abstract
Two doses of synthetic atrial natriuretic peptide (0.5 and 5.0 micrograms/min) and its vehicle were infused intravenously for 4 hours in eight salt-loaded normal volunteers, and the effect on blood pressure, heart rate, renal hemodynamics, solute excretion, and secretion of vasoactive hormones was studied. The 0.5 micrograms/min infusion did not alter blood pressure or heart rate, whereas the 5.0 micrograms/min infusion significantly reduced the mean pressure by 20/9 mm Hg after 2.5 to 3 hours and increased the heart rate slightly. Inulin clearance was not significantly changed, but the mean p-aminohippurate clearance fell by 13 and 32% with the lower and higher doses, respectively. Urinary excretion of sodium and chloride increased slightly with the lower dose. With the higher dose, a marked increase in urinary excretion of sodium, chloride, and calcium was observed, reaching a peak during the second hour of the infusion. Potassium and phosphate excretion did not change significantly. A brisk increase in urine flow rate and fractional water excretion was seen only during the first hour of the high-dose infusion. Signs and symptoms of hypotension were observed in two subjects. No change in plasma renin activity, angiotensin II, or aldosterone was observed during either infusion, but a marked increase occurred after discontinuation of the high-dose infusion. In conclusion, the 5 micrograms/min infusion induced a transient diuretic effect, delayed maximal natriuretic activity, and a late fall in blood pressure, with no change in inulin clearance but a dose-related decrease in p-aminohippurate clearance. Despite large amounts of sodium excreted and blood pressure reduction, no counterregulatory changes were observed in the renin-angiotensin-aldosterone system or plasma vasopressin levels during the infusion.Keywords
This publication has 38 references indexed in Scilit:
- Dose-Dependent Effect of Atrial Natriuretic Peptide on Blood Pressure, Heart Rate, and Skin Blood Flow of Normal VolunteersJournal of Cardiovascular Pharmacology, 1986
- ATRIAL NATRIURETIC PEPTIDE CONCENTRATIONS IN BLOOD FROM RIGHT ATRIUM IN PATIENT WITH SEVERE RIGHT HEART FAILUREThe Lancet, 1985
- Renal Effects of Human α-Atrial Natriuretic PolypeptideNew England Journal of Medicine, 1985
- Plasma Concentration of Atrial Natriuretic Factor in a Patient with Paroxysmal Atrial TachycardiaNew England Journal of Medicine, 1985
- True versus immunoreactive angiotensin II in human plasma.Hypertension, 1985
- Renal mechanism of action of rat atrial natriuretic factor.Journal of Clinical Investigation, 1985
- Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosaLife Sciences, 1984
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984
- The amino acid sequence of an atrial peptide with potent diuretic and natriuretic propertiesBiochemical and Biophysical Research Communications, 1983
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981